Ken Griffin Ark Genomic Revolution ETF (De Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Citadel Advisors LLC holds 614,900 shares of ARKG stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

614,900

Previous 623,700 1.41%

Holding current value

$16.8 Million

Previous $14.6 Million 7.49%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.89 - $27.41 $1.47 Million - $1.76 Million	64,124 Added 528.81%	76,250 $1.95 Million
Q2 2024 Aug 14, 2024	SELL	$23.01 - $28.35 $6.79 Million - $8.37 Million	-295,297 Reduced 96.06%	12,126 $284,000
Q1 2024 May 15, 2024	BUY	$27.9 - $32.96 $8.58 Million - $10.1 Million	307,423 New	307,423 $8.84 Million
Q3 2023 Nov 14, 2023	SELL	$27.6 - $38.18 $1.53 Million - $2.12 Million	-55,557 Reduced 30.14%	128,754 $3.59 Million
Q2 2023 Aug 14, 2023	BUY	$28.26 - $35.21 $3.82 Million - $4.76 Million	135,327 Added 276.27%	184,311 $6.28 Million
Q1 2023 May 15, 2023	SELL	$27.46 - $36.49 $1.97 Million - $2.62 Million	-71,718 Reduced 59.42%	48,984 $1.47 Million
Q4 2022 Feb 14, 2023	SELL	$27.08 - $36.23 $7.77 Million - $10.4 Million	-287,014 Reduced 70.4%	120,702 $3.41 Million
Q3 2022 Nov 14, 2022	SELL	$31.57 - $42.39 $1.95 Million - $2.62 Million	-61,789 Reduced 13.16%	407,716 $13.4 Million
Q2 2022 Aug 15, 2022	BUY	$27.2 - $48.94 $11.9 Million - $21.4 Million	436,404 Added 1318.4%	469,505 $14.8 Million
Q1 2022 May 16, 2022	SELL	$38.15 - $63.26 $10.4 Million - $17.3 Million	-273,758 Reduced 89.21%	33,101 $1.52 Million
Q3 2021 Nov 15, 2021	BUY	$73.87 - $92.86 $16.3 Million - $20.5 Million	221,243 Added 258.41%	306,859 $22.9 Million
Q2 2021 Aug 16, 2021	BUY	$73.64 - $93.1 $3.72 Million - $4.7 Million	50,490 Added 143.74%	85,616 $7.92 Million
Q1 2021 May 17, 2021	BUY	$81.74 - $112.47 $2.21 Million - $3.04 Million	27,011 Added 332.85%	35,126 $3.12 Million
Q3 2020 Nov 16, 2020	BUY	$53.19 - $64.24 $431,636 - $521,307	8,115 New	8,115 $517,000
Q2 2020 Aug 14, 2020	SELL	$29.13 - $53.08 $605,729 - $1.1 Million	-20,794 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.5 - $37.69 $509,453 - $783,725	20,794 New	20,794 $650,000
Q4 2019 Feb 14, 2020	SELL	$27.95 - $36.43 $1.17 Million - $1.53 Million	-41,964 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$29.35 - $35.25 $574,232 - $689,666	19,565 Added 87.35%	41,964 $1.24 Million
Q2 2019 Aug 14, 2019	SELL	$29.12 - $34.56 $686,649 - $814,924	-23,580 Reduced 51.28%	22,399 $772,000
Q4 2018 Feb 14, 2019	BUY	$22.36 - $32.61 $257,900 - $376,123	11,534 Added 33.49%	45,979 $1.1 Million
Q2 2018 Aug 10, 2018	BUY	$24.81 - $31.58 $854,580 - $1.09 Million	34,445 New	34,445 $0

Others Institutions Holding ARKG

# of Institutions

281

Shares Held

24.2M

Call Options Held

3.02M

Put Options Held

2.65M

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account